ClinicalTrials.gov record
A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
ClinicalTrials.gov ID: NCT00094367
Public ClinicalTrials.gov record NCT00094367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
See Detailed Description
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study was designed to evaluate if subjects who took 600 mg of abacavir and 300 mg of lamivudine once-daily as a single tablet were just as likely to have adverse events compared to subjects who took 300 mg of abacavir and 150 mg of lamivudine administered as separate tablets twice-daily.
Study identification
- NCT ID
- NCT00094367
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 900 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2004
- Primary completion
- Sep 30, 2005
- Completion
- Sep 30, 2005
- Last update posted
- Sep 29, 2010
2004 – 2005
United States locations
- U.S. sites
- 178
- U.S. states
- 34
- U.S. cities
- 126
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Montgomery | Alabama | 36105 | — |
| GSK Investigational Site | Glendale | Arizona | 85306 | — |
| GSK Investigational Site | Phoenix | Arizona | 85006 | — |
| GSK Investigational Site | Phoenix | Arizona | 85015 | — |
| GSK Investigational Site | Tucson | Arizona | 85745 | — |
| GSK Investigational Site | Arleta | California | 91331 | — |
| GSK Investigational Site | Beverly Hills | California | 90210 | — |
| GSK Investigational Site | Beverly Hills | California | 90211 | — |
| GSK Investigational Site | Fresno | California | 93720 | — |
| GSK Investigational Site | Long Beach | California | 90801 | — |
| GSK Investigational Site | Long Beach | California | 90806 | — |
| GSK Investigational Site | Long Beach | California | 90813 | — |
| GSK Investigational Site | Los Angeles | California | 90022 | — |
| GSK Investigational Site | Los Angeles | California | 90027 | — |
| GSK Investigational Site | Los Angeles | California | 90028 | — |
| GSK Investigational Site | Los Angeles | California | 90048 | — |
| GSK Investigational Site | Los Angeles | California | 90067 | — |
| GSK Investigational Site | Newport Beach | California | 92663 | — |
| GSK Investigational Site | Oakland | California | 94602 | — |
| GSK Investigational Site | Oakland | California | 94609 | — |
| GSK Investigational Site | Palm Springs | California | 92262 | — |
| GSK Investigational Site | Panorama City | California | 91402 | — |
| GSK Investigational Site | Paramount | California | 90723 | — |
| GSK Investigational Site | Riverside | California | 92507 | — |
| GSK Investigational Site | Salinas | California | 93912 | — |
| GSK Investigational Site | San Francisco | California | 94102 | — |
| GSK Investigational Site | San Francisco | California | 94114 | — |
| GSK Investigational Site | Santa Rosa | California | 95404 | — |
| GSK Investigational Site | Tarzana | California | 30342 | — |
| GSK Investigational Site | Tarzana | California | 91356 | — |
| GSK Investigational Site | Denver | Colorado | 80204 | — |
| GSK Investigational Site | Denver | Colorado | 80205 | — |
| GSK Investigational Site | Denver | Colorado | 80206 | — |
| GSK Investigational Site | Glastonbury | Connecticut | 06033 | — |
| GSK Investigational Site | New Haven | Connecticut | 06520 | — |
| GSK Investigational Site | Norwalk | Connecticut | 06851 | — |
| GSK Investigational Site | Stamford | Connecticut | 06902 | — |
| GSK Investigational Site | Stratford | Connecticut | 06614 | — |
| GSK Investigational Site | Washington D.C. | District of Columbia | 20037 | — |
| GSK Investigational Site | Coral Gables | Florida | 33134 | — |
| GSK Investigational Site | Coral Springs | Florida | 33065 | — |
| GSK Investigational Site | Daytona Beach | Florida | 32114 | — |
| GSK Investigational Site | Fort Lauderdale | Florida | 33145 | — |
| GSK Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| GSK Investigational Site | Fort Lauderdale | Florida | 33316 | — |
| GSK Investigational Site | Fort Myers | Florida | 33901 | — |
| GSK Investigational Site | Gainesville | Florida | 32601 | — |
| GSK Investigational Site | Inmokalee | Florida | 34142 | — |
| GSK Investigational Site | Key West | Florida | 33040 | — |
| GSK Investigational Site | Melbourne | Florida | 32935 | — |
| GSK Investigational Site | Miami | Florida | 33133 | — |
| GSK Investigational Site | Miami | Florida | 33176 | — |
| GSK Investigational Site | Miami Beach | Florida | 33139 | — |
| GSK Investigational Site | North Miami | Florida | 33161 | — |
| GSK Investigational Site | Orlando | Florida | 32803 | — |
| GSK Investigational Site | Orlando | Florida | 32804 | — |
| GSK Investigational Site | Orlando | Florida | 32806 | — |
| GSK Investigational Site | Pampano | Florida | 33062 | — |
| GSK Investigational Site | Pembroke Pines | Florida | 33024 | — |
| GSK Investigational Site | Plantation | Florida | 33317 | — |
| GSK Investigational Site | Pompano Beach | Florida | 33062 | — |
| GSK Investigational Site | Port Saint Lucie | Florida | 34952 | — |
| GSK Investigational Site | Sarasota | Florida | 34239 | — |
| GSK Investigational Site | South Miami | Florida | 33143 | — |
| GSK Investigational Site | St. Petersburg | Florida | 33710 | — |
| GSK Investigational Site | Tallahassee | Florida | 32308 | — |
| GSK Investigational Site | Tamarac | Florida | 33321 | — |
| GSK Investigational Site | Tampa | Florida | 33614 | — |
| GSK Investigational Site | West Palm Beach | Florida | 33401 | — |
| GSK Investigational Site | West Palm Beach | Florida | 33408 | — |
| GSK Investigational Site | Atlanta | Georgia | 30308/30309 | — |
| GSK Investigational Site | Atlanta | Georgia | 30309 | — |
| GSK Investigational Site | Atlanta | Georgia | 30312 | — |
| GSK Investigational Site | Atlanta | Georgia | 30318 | — |
| GSK Investigational Site | Atlanta | Georgia | 30329 | — |
| GSK Investigational Site | Atlanta | Georgia | 30342 | — |
| GSK Investigational Site | Austell | Georgia | 30106 | — |
| GSK Investigational Site | Columbus | Georgia | 31906 | — |
| GSK Investigational Site | Decatur | Georgia | 30033 | — |
| GSK Investigational Site | Lawrenceville | Georgia | 30045 | — |
| GSK Investigational Site | Riverdale | Georgia | 30274 | — |
| GSK Investigational Site | Boise | Idaho | 83704 | — |
| GSK Investigational Site | Chicago | Illinois | 60643 | — |
| GSK Investigational Site | Elgin | Illinois | 60120 | — |
| GSK Investigational Site | Joliet | Illinois | 60432 | — |
| GSK Investigational Site | Indianapolis | Indiana | 46204 | — |
| GSK Investigational Site | Des Moines | Iowa | 50309-1426 | — |
| GSK Investigational Site | Henderson | Kentucky | 42420 | — |
| GSK Investigational Site | Louisville | Kentucky | 40202 | — |
| GSK Investigational Site | Baton Rouge | Louisiana | 70816 | — |
| GSK Investigational Site | New Orleans | Louisiana | 70115 | — |
| GSK Investigational Site | New Orleans | Louisiana | 70117 | — |
| GSK Investigational Site | New Orleans | Louisiana | 70121 | — |
| GSK Investigational Site | Baltimore | Maryland | 21201 | — |
| GSK Investigational Site | Baltimore | Maryland | 21209 | — |
| GSK Investigational Site | Baltimore | Maryland | 21218 | — |
| GSK Investigational Site | Baltimore | Maryland | 21229-5299 | — |
| GSK Investigational Site | Bethesda | Maryland | 20816 | — |
| GSK Investigational Site | Clinton | Maryland | 20735 | — |
| GSK Investigational Site | Silver Spring | Maryland | 20910 | — |
| GSK Investigational Site | Lowell | Massachusetts | 01854 | — |
| GSK Investigational Site | Springfield | Massachusetts | 01107 | — |
| GSK Investigational Site | Berkeley | Michigan | 48072 | — |
| GSK Investigational Site | Grand Rapids | Michigan | 49503 | — |
| GSK Investigational Site | Lansing | Michigan | 48910 | — |
| GSK Investigational Site | Saint Louis | Michigan | 63117 | — |
| GSK Investigational Site | Chesterfield | Missouri | 63017 | — |
| GSK Investigational Site | Columbia | Missouri | 65212 | — |
| GSK Investigational Site | Kansas City | Missouri | 64112 | — |
| GSK Investigational Site | Kansas City | Missouri | 64132 | — |
| GSK Investigational Site | Henderson | Nevada | 89015 | — |
| GSK Investigational Site | Las Vegas | Nevada | 79102 | — |
| GSK Investigational Site | Lebanon | New Hampshire | 03756 | — |
| GSK Investigational Site | East Orange | New Jersey | 07017 | — |
| GSK Investigational Site | Englewood | New Jersey | 07631 | — |
| GSK Investigational Site | Galloway | New Jersey | 08205 | — |
| GSK Investigational Site | Hoboken | New Jersey | 07030 | — |
| GSK Investigational Site | Jersey City | New Jersey | 07304 | — |
| GSK Investigational Site | Jersey City | New Jersey | 07306 | — |
| GSK Investigational Site | Newark | New Jersey | 07101-1709 | — |
| GSK Investigational Site | Newark | New Jersey | 07102 | — |
| GSK Investigational Site | Newark | New Jersey | 07112 | — |
| GSK Investigational Site | Somers Point | New Jersey | 08244 | — |
| GSK Investigational Site | Westfield | New Jersey | 07090 | — |
| GSK Investigational Site | Santa Fe | New Mexico | 87505 | — |
| GSK Investigational Site | Albany | New York | 12208 | — |
| GSK Investigational Site | Brooklyn | New York | 11201 | — |
| GSK Investigational Site | Brooklyn | New York | 11212 | — |
| GSK Investigational Site | Brooklyn | New York | 11215 | — |
| GSK Investigational Site | Brooklyn | New York | 11220 | — |
| GSK Investigational Site | Brooklyn | New York | 11237 | — |
| GSK Investigational Site | Great Neck | New York | 10020 | — |
| GSK Investigational Site | Manhasset | New York | 11030 | — |
| GSK Investigational Site | New York | New York | 10003 | — |
| GSK Investigational Site | New York | New York | 10010 | — |
| GSK Investigational Site | New York | New York | 10011 | — |
| GSK Investigational Site | New York | New York | 10016 | — |
| GSK Investigational Site | New York | New York | 10019 | — |
| GSK Investigational Site | New York | New York | 10022 | — |
| GSK Investigational Site | New York | New York | 10025 | — |
| GSK Investigational Site | Staten Island | New York | 10304 | — |
| GSK Investigational Site | The Bronx | New York | 10457 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28211 | — |
| GSK Investigational Site | Huntersville | North Carolina | 28078 | — |
| GSK Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| GSK Investigational Site | Cleveland | Ohio | 44109 | — |
| GSK Investigational Site | Portland | Oregon | 97209 | — |
| GSK Investigational Site | Danville | Pennsylvania | 17822 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19121 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19131 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19143 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19146 | — |
| GSK Investigational Site | Reading | Pennsylvania | 19601 | — |
| GSK Investigational Site | Greenville | South Carolina | 29605 | — |
| GSK Investigational Site | Spartanburg | South Carolina | 29303 | — |
| GSK Investigational Site | Johnson City | Tennessee | 37614 | — |
| GSK Investigational Site | Memphis | Tennessee | 38104 | — |
| GSK Investigational Site | Memphis | Tennessee | 38120 | — |
| GSK Investigational Site | Arlington | Texas | 76015 | — |
| GSK Investigational Site | Austin | Texas | 78705 | — |
| GSK Investigational Site | Dallas | Texas | 75219 | — |
| GSK Investigational Site | Dallas | Texas | 75235 | — |
| GSK Investigational Site | El Paso | Texas | 79905 | — |
| GSK Investigational Site | Galveston | Texas | 77555-0188 | — |
| GSK Investigational Site | Houston | Texas | 77004 | — |
| GSK Investigational Site | Houston | Texas | 77009 | — |
| GSK Investigational Site | Houston | Texas | 77027 | — |
| GSK Investigational Site | Houston | Texas | 77098 | — |
| GSK Investigational Site | Longview | Texas | 75604 | — |
| GSK Investigational Site | San Antonio | Texas | 78229 | — |
| GSK Investigational Site | Tyler | Texas | 75708 | — |
| GSK Investigational Site | Salt Lake City | Utah | 84132 | — |
| GSK Investigational Site | Annandale | Virginia | 22003 | — |
| GSK Investigational Site | Fairfax | Virginia | 22030 | — |
| GSK Investigational Site | Richmond | Virginia | 23224 | — |
| GSK Investigational Site | Spokane | Washington | 99204 | — |
| GSK Investigational Site | Milwaukee | Wisconsin | 53212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00094367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2010 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00094367 live on ClinicalTrials.gov.